Musk envisions an eventual $20K–$30K price tag, but ramping to his goal of one million units by 2035 demands an exponential ...
Sarah Giles of inVentiv Health explores new ways to tackle pharma market access challenges in China. Through their role in effectively managing budgets to improve population-level health outcomes, ...
Novartis has started the first phase of a programme that will make 15 of its essential medicines available in lower-income countries for just $1 per drug per month. The Novartis Access scheme – first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results